Short Bowel Syndrome (SBS) is a multifaceted condition arising from extensive surgical resection of the small intestine, which leads to impaired nutrient absorption and a heightened risk of ...

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family companies Napo Pharmaceuticals (Napo) and Napo Therapeutics today announced that the first short bowel syndrome with intestinal failure (SBS-IF) ...

Teduglutide (Revestive, Nycomed/Takeda, in the European Union; Gattex, NPS Pharmaceuticals, in the United States) appears to reduce the need for parenteral support in patients with short bowel ...

This new IP supports crofelemer's global exclusivity in rare pediatric intestinal failure coincident with published clinical data showing reductions in parenteral support requirements with crofelemer ...

Preclinical Data for OPK-8801003 Demonstrate Substantially Longer Biological Half-Life with Peak Plasma Levels Comparable to Gattex ®, the Only Approved GLP-2 Therapy Oral GLP-2 Tablet Could Transform ...

SATB2 deficiency confers small intestinal (ileal) properties on colon cells. Green fluorescent marker bound to cholesterol (top row) and glucose (bottom row) shows absorption of nutrients in: a) Ileal ...

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present new findings at the American College of Gastroenterology (ACG) 2024 Annual ...

Patients with short bowel syndrome are the most complex of patients in gastroenterology. Proper management of these patients -- to treat and to avoid disease and therapy-related complications in a ...

Researchers used human intestinal organoids in their study. This confocal immunofluorescence image shows a stem cell-derived human intestinal organoid treated with zinc. Researchers from Johns Hopkins ...